Placental size and the prediction of severe early‐onset intrauterine growth restriction in women with low pregnancy‐associated plasma protein‐A
Open Access
- 11 August 2009
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 34 (3) , 274-282
- https://doi.org/10.1002/uog.7308
Abstract
Objectives Screening studies for trisomy 21 demonstrate that low maternal serum pregnancy‐associated plasma protein‐A (PAPP‐A) at 11–13 weeks' gestation is associated with stillbirth, intrauterine growth restriction (IUGR) and pre‐eclampsia in chromosomally normal fetuses. However, the strength of these associations is too weak to justify screening for these placental insufficiency syndromes. Our objective was to evaluate placental size and uterine artery (UtA) Doppler imaging as second‐stage screening tests for women with low PAPP‐A. Methods We prospectively studied 90 normal singleton pregnancies with first‐trimester PAPP‐A ≤ 0.30 multiples of the median. Maternal serum α‐fetoprotein (AFP) at 15–18 weeks' gestation, and second‐trimester placental size and UtA Doppler indices were assessed as predictors of pregnancy outcome. Results The risks of IUGR, preterm delivery before 32 weeks' gestation and stillbirth were significantly associated with small placental size (relative risk (RR), 3.96; 95% CI, 2.21–5.98; RR, 3.96; 95% CI, 2.21–5.98; and RR, 6.44, 95% CI, 2.74–14.54, respectively) and elevated AFP (RR, 3.67; 95% CI, 1.78–7.71; RR, 2.48; 95% CI, 1.23–4.94; and RR, 5.14; 95% CI, 1.66–16.85, respectively), but not with abnormal UtA Doppler indices. The combination of elevated AFP and small placental size further increased the risk of IUGR (RR, 4.88; 95% CI, 2.88–5.31), delivery before 32 weeks' gestation (RR, 4.25; 95% CI, 2.38–4.98) and stillbirth (RR, 7.44; 95% CI, 3.04–3.75). Conclusions Small placental size and elevated AFP, but not UtA Doppler indices, identify women with low PAPP‐A at high risk of IUGR, extreme preterm delivery and stillbirth. These additional screening tests may directly improve perinatal outcomes in women with low PAPP‐A. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysisCurrent Medical Research and Opinion, 2008
- Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysisCMAJ : Canadian Medical Association Journal, 2008
- Predictors of Neonatal Outcome in Early- Onset Placental DysfunctionObstetrics & Gynecology, 2007
- The “Consecutive Combined Test”—using Double test from week 8 + 0 and Nuchal Translucency Scan, for first trimester screening for Down SyndromePrenatal Diagnosis, 2006
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2004
- Diagnosis and management of preeclampsia and eclampsiaInternational Journal of Gynecology & Obstetrics, 2002
- Messenger Ribonucleic Acid Levels of Pregnancy-Associated Plasma Protein-A and the Proform of Eosinophil Major Basic Protein: Expression in Human Reproductive and Nonreproductive Tissues1Biology of Reproduction, 1999
- The relation between fetal abdominal circumference and birthweight: findings in 3512 pregnanciesBJOG: An International Journal of Obstetrics and Gynaecology, 1997